Xenon Pharmaceuticals Inc.

Pharmaceutical Preparations·BURNABY·FY end 12/31·CIK 1582313

Overview Financials Compensation Governance Insiders Filings

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Ian MortimerPresident and Chief Executive Officer	$786.0K	$1.8M	$6.1M	$550.2K	$46.3K	$9.2M
Thomas Kelly	$114.5K	$1.3M	$5.8M	$51.5K	$6.0K	$7.2M
Darren Cline	$279.7K	—	$3.6M	$125.8K	$14.6K	$4.0M
Christopher KenneyChief Medical Officer	$565.0K	$532.2K	$1.8M	$254.3K	$29.4K	$3.1M
Andrea DiFabioChief Legal Officer and Corporate Secretary	$510.0K	$532.2K	$1.8M	$229.5K	$26.7K	$3.1M
Sherry AulinFormer Chief Financial Officer	$330.4K	—	—	$1.5K	$24.5K	$356.5K

CEO pay mix

Ian Mortimer · FY 2025

Stock awards$1.8M19%

Performance bonus$550.2K6%

Salary$786.0K9%

Other$6.1M66%

Performance vs. pay

Item 402(v) Pay-Versus-Performance disclosure data not yet ingested for this company. Mandatory only for FYs ending on/after Dec 16, 2022 — older companies may not have filed it yet.

CEO comp · median worker · ratio — 4-year trend

CEO total compMedian employeePay ratio (right axis)